The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology (Q36511032)

14 August 2017

1 reference

title

The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology (English)

1 reference

14 August 2017

main subject

venous thromboembolism

1 reference

Paul C Winter

1 reference

14 August 2017

publication date

1 September 2006

1 reference

14 August 2017

published in

Hematological Oncology

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

126-133

1 reference

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

14 August 2017

cites work

1 reference

Mechanisms of disease: the impact of antithrombotic therapy in cancer patients

21 January 2018

1 reference

Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues

21 January 2018

1 reference

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

21 January 2018

1 reference

7 January 2021

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

7 January 2021

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

7 January 2021

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

1 reference

7 January 2021

Molecular basis for the relationship between thrombosis and cancer

1 reference

7 January 2021

Cancer and venous thromboembolism.

1 reference

7 January 2021

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

1 reference

7 January 2021

Regulation of angiogenesis by tissue factor cytoplasmic domain signaling

1 reference

7 January 2021

New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia

1 reference

7 January 2021

Thrombotic complications of central venous catheters in cancer patients

1 reference

7 January 2021

Budd-Chiari syndrome as the first manifestation of polycythemia vera in young women with inherited thrombophilic state: an aggressive form of myeloproliferative disorder requiring multidisciplinary management

1 reference

7 January 2021

Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management

1 reference

7 January 2021

Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications

1 reference

7 January 2021

Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations

1 reference

7 January 2021

Epidemiology of thrombosis in cancer

1 reference

7 January 2021

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study

1 reference

7 January 2021

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

7 January 2021

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

1 reference

7 January 2021

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

7 January 2021

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

1 reference

7 January 2021

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

1 reference

7 January 2021

Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis

1 reference

7 January 2021

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

1 reference

7 January 2021

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

7 January 2021

Complication rates among cancer patients with peripherally inserted central catheters

1 reference

7 January 2021

Structural design and molecular evolution of a cytokine receptor superfamily

1 reference

7 January 2021

Initiation of blood coagulation: the tissue factor/factor VIIa complex

1 reference

7 January 2021

Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody

1 reference

7 January 2021

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

7 January 2021

Update on tumor cell procoagulant factors

1 reference

7 January 2021

A factor X-activating cysteine protease from malignant tissue

1 reference

7 January 2021

Cancer procoagulant stimulates platelet adhesion

1 reference

7 January 2021

Free radicals are involved in cancer procoagulant-induced platelet activation

1 reference

7 January 2021

Fibrinolysis and cancer

1 reference

7 January 2021

Pathogenesis of increased risk of thrombosis in cancer.

1 reference

7 January 2021

The plasminogen-plasmin system in malignancy

1 reference

7 January 2021

The role of the plasminogen activation system in cancer.

1 reference

7 January 2021

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

7 January 2021

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

1 reference

7 January 2021

Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

1 reference

7 January 2021

On the origin of leukocyte procoagulant activity

1 reference

7 January 2021

Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway

1 reference

7 January 2021

Pathogenesis of thrombosis in patients with malignancy.

1 reference

7 January 2021

The prothrombotic state in cancer: pathogenic mechanisms

1 reference

7 January 2021

Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer

1 reference

7 January 2021

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis

1 reference

7 January 2021

Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis

1 reference

7 January 2021

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

7 January 2021

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

1 reference

7 January 2021

Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma

1 reference

7 January 2021

Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis

1 reference

7 January 2021

Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation

1 reference

7 January 2021

Role of tissue factor in embryonic blood vessel development.

1 reference

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

7 January 2021

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

1 reference

7 January 2021

Thrombin and platelet activation

1 reference

7 January 2021

Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways

1 reference

7 January 2021

Tissue factor-factor VIIa signaling

1 reference

7 January 2021

Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain

1 reference

7 January 2021

A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280

1 reference

7 January 2021

Coagulation factors VIIa and Xa inhibit apoptosis and anoikis

1 reference

7 January 2021

Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line

1 reference

7 January 2021

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration

1 reference

7 January 2021

Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene

1 reference

7 January 2021

Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: Up-regulation of poly(A) polymerase

1 reference

7 January 2021

Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction

1 reference

7 January 2021

Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice

1 reference

7 January 2021

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

1 reference

7 January 2021

Tissue factor, thrombin, and cancer

1 reference

7 January 2021

Molecular mechanisms of thrombin-induced endothelial cell permeability

1 reference

7 January 2021

Thrombin signalling and protease-activated receptors

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.785

1 reference

14 August 2017

1 reference